Research Article
Retrospective Analysis of Adoptive TIL Therapy plus Anti-PD1 Therapy in Patients with Chemotherapy-Resistant Metastatic Osteosarcoma
Table 2
Treatment-related adverse events in patients in response to therapy (
).
| Side effects | No. (%) of patients associated with adverse events | Grade 1 or 2 | Grade 3 or 4 |
| Fever | 30 (50) | 2 (3.33) | Fatigue | 15 (25) | 0 | Rash | 11 (18.33) | 0 | Anorexia | 13 (21.67) | 0 | Leukopenia | 9 (15) | 0 | Anemia | 8 (13.33) | 0 | Vitiligo | 0 | 0 | Nausea | 0 | 0 | Vomiting | 0 | 0 | Total incidence | 43 (71.67) | 2 (3.33) |
|
|